Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	1.63	1.56	1.04	0.81	0.82
Research & Development	7.7	6.48	3.56	1.06	2.61
Operating Expenses	9.33	8.04	4.6	1.86	3.43
Operating Income	-9.33	-8.04	-4.6	-1.86	-3.43
Other Expense / Income	-0.44	-0.22	-0.03	-0	-
Pretax Income	-8.89	-7.83	-4.57	-1.86	-3.43
Net Income	-8.89	-7.83	-4.57	-1.86	-3.43
Shares Outstanding (Basic)	13	13	13	9	2
Shares Outstanding (Diluted)	13	13	13	9	2
Shares Change	-0.51%	-0.23%	36.27%	320.69%	1012.33%
EPS (Basic)	-0.69	-0.61	-0.35	-0.20	-1.52
EPS (Diluted)	-0.69	-0.61	-0.35	-0.20	-1.52
Free Cash Flow	-6.48	-6.2	-4.29	-1.15	-0.29
Free Cash Flow Per Share	-0.50	-0.48	-0.33	-0.12	-0.13
EBITDA	-8.89	-7.82	-4.57	-1.86	-3.42
Depreciation & Amortization	0	0	0	0	0
EBIT	-8.89	-7.83	-4.57	-1.86	-3.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).